Rifaximin

Rifaximin Reactions 1680, p297 - 2 Dec 2017 Abdominal pain, vomiting and discolouration of teeth: 3 case reports In a retrospective observational study (IMPRESS) of 207 patients, 3 patients [ages and sexes not stated] were described, who developed abdominal pain, vomiting or discolouration of teeth during treatment with rifaximin [rifaximin-α; routes, dosages and duration of treatments to reactions onset not stated]. The patients, who had hepatic encephalopathy (HE), received treatment with rifaximin. Subsequently, the patients developed abdominal pain (1 patient), vomiting (1 patient) and showed discolouration of teeth (1 patient) [outcomes not stated]. Author comment: "Nine patients (4%) had documented [adverse events]: Clostridium difficile infection (n=4), rash (n=2), abdominal pain, vomiting and discolouration of teeth (one patient each)." "The low number of [adverse events] and C difficile cases in our study demonstrates good tolerability and is consistent with both the clinical trials of rifaximin-α and previous [United Kingdom] audits." Hudson M, et al. The impact of rifaximin-alpha on the hospital resource use associated with the management of patients with hepatic encephalopathy: A retrospective observational study (IMPRESS). Frontline Gastroenterology 8: 243-251, No. 4, 1 Oct 2017. Available from: URL: http://doi.org/10.1136/ flgastro-2016-100792 - United Kingdom 803285005 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Rifaximin

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Free
1 page

Loading next page...
1 Page
 
/lp/springer_journal/rifaximin-wvOPxEdFfU
Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-39228-5
Publisher site
See Article on Publisher Site

Abstract

Reactions 1680, p297 - 2 Dec 2017 Abdominal pain, vomiting and discolouration of teeth: 3 case reports In a retrospective observational study (IMPRESS) of 207 patients, 3 patients [ages and sexes not stated] were described, who developed abdominal pain, vomiting or discolouration of teeth during treatment with rifaximin [rifaximin-α; routes, dosages and duration of treatments to reactions onset not stated]. The patients, who had hepatic encephalopathy (HE), received treatment with rifaximin. Subsequently, the patients developed abdominal pain (1 patient), vomiting (1 patient) and showed discolouration of teeth (1 patient) [outcomes not stated]. Author comment: "Nine patients (4%) had documented [adverse events]: Clostridium difficile infection (n=4), rash (n=2), abdominal pain, vomiting and discolouration of teeth (one patient each)." "The low number of [adverse events] and C difficile cases in our study demonstrates good tolerability and is consistent with both the clinical trials of rifaximin-α and previous [United Kingdom] audits." Hudson M, et al. The impact of rifaximin-alpha on the hospital resource use associated with the management of patients with hepatic encephalopathy: A retrospective observational study (IMPRESS). Frontline Gastroenterology 8: 243-251, No. 4, 1 Oct 2017. Available from: URL: http://doi.org/10.1136/ flgastro-2016-100792 - United Kingdom 803285005 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680

Journal

Reactions WeeklySpringer Journals

Published: Dec 2, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off